Navigation Links
Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders
Date:12/5/2007

tol-Myers Squibb Company, Genentech, Inc. and N.V. Organon. For additional information about Lexicon and its programs, please visit http://www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's clinical development of LX6171 and the potential therapeutic and commercial potential of LX6171. This press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information. All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX6171 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2006, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
2. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
3. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
4. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
9. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
10. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... April 20, 2015 This report analyzes the ... US$ Million. The report provides separate comprehensive analytics for ... Europe , and Rest of World. Annual estimates ... 2020. Also, a seven-year historic analysis is provided for ... primary and secondary research. Company profiles are primarily based ...
(Date:4/20/2015)...  Sigma-Aldrich Corporation (Nasdaq: SIAL ) was ... of the 100 Best Corporate Citizens, which ranks ... Sigma-Aldrich ranked fifth, its highest ranking to date, ... "We are honored to be recognized once ... are extremely pleased with our ranking," said ...
(Date:4/20/2015)... , April 20, 2015   Spirox ... today the closing of an $18.5 million Series B round ... Existing investors Aperture Venture Partners, Correlation Ventures and ... Spirox, which is developing a novel, minimally invasive ... Throat (ENT) physicians and plastic surgeons to treat ...
Breaking Medicine Technology:World Medical Equipment Rental and Leasing Industry 2World Medical Equipment Rental and Leasing Industry 3World Medical Equipment Rental and Leasing Industry 4World Medical Equipment Rental and Leasing Industry 5World Medical Equipment Rental and Leasing Industry 6World Medical Equipment Rental and Leasing Industry 7Sigma-Aldrich Named to CR Magazine's 100 Best Corporate Citizens List 2Spirox, Inc. Announces Closing of $18.5MM Series B Financing 2Spirox, Inc. Announces Closing of $18.5MM Series B Financing 3
... , , SOLNA, Sweden , ... Exchange: AERO) today announced that a group of prominent clinicians ... the US, has issued a consensus paper recommending that inflammation ... routine clinical management of asthma in conjunction with other conventional ...
... to develop automated system to better control diabetes represents first ... YORK , Jan. 13 The Juvenile Diabetes ... to develop an automated system to help people with type ... on the path to what would be among the most ...
Cached Medicine Technology:US Expert Panel Recommends the Use of Fractional Exhaled Nitric Oxide (FENO) in the Diagnosis and Management of Asthma 2US Expert Panel Recommends the Use of Fractional Exhaled Nitric Oxide (FENO) in the Diagnosis and Management of Asthma 3US Expert Panel Recommends the Use of Fractional Exhaled Nitric Oxide (FENO) in the Diagnosis and Management of Asthma 4JDRF Forms Partnership With Animas to Develop First-Generation Automated System for Managing Type 1 Diabetes 2JDRF Forms Partnership With Animas to Develop First-Generation Automated System for Managing Type 1 Diabetes 3JDRF Forms Partnership With Animas to Develop First-Generation Automated System for Managing Type 1 Diabetes 4JDRF Forms Partnership With Animas to Develop First-Generation Automated System for Managing Type 1 Diabetes 5
(Date:4/21/2015)... The Northeast Football Clinic (NEFC) has trained ... school in Byfield, MA. Applications are being accepted for ... grades 6-12. , The outstanding professional, college, and high ... , Offensive and defensive linemen and linebackers ... most unsung positions on the field, the the success ...
(Date:4/21/2015)... 2015 Freeslate, Inc ., the ... today announced that the Centre for Catalysis Research ... has acquired a Freeslate Core Module 3 (CM3) ... (SPR) to accelerate current research programs. The systems ... they will be available to academic users and industrial ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 This ... pathologists, physical therapist assistants, occupational therapist assistants, teachers, ... and techniques to help children across the autism ... through Education Resources Inc. , ... 2008, this highly acclaimed yoga curriculum addresses learning ...
(Date:4/20/2015)... Draft, Virginia (PRWEB) April 20, 2015 ... Augusta Health facility in Stuarts Draft, an independent, ... County, Staunton, and Waynesboro, Virginia. The project was ... Architects. The Stuarts Draft facility is expected to ... , Located on Stuarts Draft Highway, the new ...
(Date:4/20/2015)... April 21, 2015 The National ... Binau, Founder of Soul Care Group, Inc., as ... is recognized with this prestigious distinction for leadership in ... Local Chapters, NAPW is the nation's leading networking organizaiton ... Susan with our Woman of the Year Award,” says ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 3Health News:ABC News Interviews Anne Buckley-Reen, Education Resources Inc. Faculty Member, on Yoga Therapy in the Classroom 2Health News:Augusta Health Construction Wraps Up at Stuarts Draft 2Health News:National Association of Professional Women Announces Susan Binau, Founder of Soul Care Group, Inc., a 2015 Professional Woman of the Year 2
... Stabilized ... ENADH NADH, ... and distributor of nadh branded nutritional products, has,obtained the exclusive distribution ... the USA. ENADA,NADH was the original nadh product, stabilized by Prof. ...
... Breathing,Resistance Exerciser has been selected as the ... L.A. Times. Jorge Brouwer, inventor of the ... the easy,to use "Expand-A-Lung.", *(PHOTO ... Resistance Exerciser.) When asked about how ...
... Life Sciences,Inc. (TSX: BNC), a research-based, technology-driven Canadian,biopharmaceutical ... vaccine at the 6th Congress of Medical Microbiology ... presentation was made by Dr. Dragan,Rogan, Vice-President, Bioniche ... vaccine is the world,s first vaccine that may ...
... June 17 For women about to give,birth, one ... ensuring they have on,hand the right music., (Photo: ... studies have found that music can reduce,anxiety and stress ... "There,s a lot of pain and discomfort that can ...
... Research in the United States has shown that obese people ... for breast, colon and cervical cancer. Raj Padwal, Rebecca Mitchell ... Medicine & Dentistry, have undertaken a study to see if ... obesity is associated with higher rates of some types of ...
... ,lack of motivation, ,lack of money, and ,lack of time, as, ... ... health, SANTA MONICA, Calif., June 17 Findings from a ... to improve their overall health, but less than half of those ...
Cached Medicine News:Health News:ENADA NADH Is Back 2Health News:Have You Exercised Your Lungs Today? 2Health News:Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia 2Health News:Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia 3Health News:Using Music to Ease the Pain of Labor; New CD Featuring Celine Dion, Norah Jones, Provides Soothing Songs for Delivery 2Health News:Obese women in Canada are less likely to be screened for cervical cancer 2Health News:LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful 2Health News:LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful 3Health News:LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful 4
Turnstile casting stand for easy and safe casting. The compact system sets up quickly and stores conveniently, and the non-stick coating prevents fiberglass or plaster from adhering to surface....
Bone cement with Gentamicin 2.5%....
... Techno-Aide provides the highest level of ... quality lead protective eyewear. Consistent ... tolerance allowed. Mfg supervised by Licensed ... lens meet or exceed standards for ...
... Comfort fit large designer ... adjustable strap bridge providing a ... on the nose. The head ... for custom fit. The acrylic ...
Medicine Products: